News of revenue will move the SP.
I'm not sure anything else will, although I'd be happy if it did.
Building the mfg facility is only important if somebody is buying what CYGX is manufacturing, and in enough quantity to justify the multi-million dollar price tag. Currently, we've seen news of orders and re-orders, but we've seen no figures at all for revenue, and without them, everything is speculation.
This company could (and may well) have the most impressive technology within their area of expertise, but that doesn't equate to success. The only way for any company to succeed is by selling something, and CYGX - for all their technical prowess - has yet to conclusively demonstrate that they know how to do this at all, let alone consistently enough to ensure ongoing financial viability.
Now, I know that they've release news of orders and re-orders. But without even a general summary of the type of revenue generated with those orders, nobody can effectively estimate the revenue-generating potential of this company - and since we all buy our stock based on its potential, that lack of hard figures pretty much locks us into a narrow price band in which speculative investors with higher risk thresholds are interested (i.e. I might pay a buck a share for something like this, but I ain't payin' 3 bucks a share!). Let's face it, nobody disbelieves that they've received and even filled orders, but I have personally seen no evidence at all that they've received so much as a single dollar of revenue yet. Yet this does not alarm me at a buck a share...
Current CYGX stockholders (like me) are not here for anything that this company has done. We're here for what we think it might do. The majority of successful investors, however, only allot a small portion of their capital to this sort of speculation, and the rest they put into companies that are demonstrably performing well - either through growth, margin management, or dividend returns. When CYGX finally shows sufficient revenue, then the stock will be a candidate to tap that larger reservoir of investor capital available to companies that are less risky - and the demand for the stock will rise, driving the price higher. True, sensational news of a cure or vaccine could also drive the price up temporarily, but only insofar as people in general would expect an eventual revenue result from capitalization of the product - and if it failed to materialize in a fairly short amount of time, the stock price would plummet again.
Right now, man, you don't get much riskier than a company like this. They don't generate revenue, and they dilute the heck out of their stock to sustain operations. But they've got some technology that's potentially the hottest thing in a decade for this sector.
Mfg facility news, good. Revenue news, critical.
GBUA
News 
Market Data 
Discover 
